Rice Hall James & Associates, LLC Puma Biotechnology, Inc. Transaction History
Rice Hall James & Associates, LLC
- $1.54 Billion
- Q2 2024
A detailed history of Rice Hall James & Associates, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 144,792 shares of PBYI stock, worth $369,219. This represents 0.03% of its overall portfolio holdings.
Number of Shares
144,792
Previous 140,106
3.34%
Holding current value
$369,219
Previous $742,000
36.39%
% of portfolio
0.03%
Previous 0.05%
Shares
28 transactions
Others Institutions Holding PBYI
# of Institutions
98Shares Held
30.5MCall Options Held
73.5KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA3.6MShares$9.18 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$9.11 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.16MShares$8.06 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.06MShares$7.81 Million0.59% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$4.98 Million0.02% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $116M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...